CA2739465C — Compositions and methods for the treatment of bowel diseases with granulated mesalamine
Assigned to Dr Falk Pharma GmbH · Expires 2017-01-31 · 9y expired
What this patent protects
Disclosed are methods for treating gastrointestinal disorders, e.g., Crohn's disease, ulcerative colitis, and diverticu-lar disease, with a granulated mesalamine formulation. Some formulations use granulated mesalamine in capsule form. Also in-cluded are methods to extend remissi…
USPTO Abstract
Disclosed are methods for treating gastrointestinal disorders, e.g., Crohn's disease, ulcerative colitis, and diverticu-lar disease, with a granulated mesalamine formulation. Some formulations use granulated mesalamine in capsule form. Also in-cluded are methods to extend remission of ulcerative colitis by administration of a once -daily dosage of granulated mesalamine.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.